AstraZeneca's Major Investment Boost in India's Healthcare Sector
AstraZeneca has announced an investment of Rs 176 crore in India to enhance its Global Innovation and Technology Centre in Chennai. This move, revealed during the TN Rising London campaign, strengthens AstraZeneca's commitment to advancing technology and healthcare innovation.
- Country:
- India
Global bio-pharmaceutical giant AstraZeneca has pledged Rs 176 crore in India, focusing on bolstering its Global Innovation and Technology Centre in Chennai to drive advancements in healthcare technology and innovation.
The announcement was made during the TN Rising London campaign, organized by the Tamil Nadu government and coinciding with Chief Minister M K Stalin's UK visit.
This marks AstraZeneca's third significant investment move, following its Rs 166 crore investment in June for a Bengaluru hub, and a projected Rs 250 crore investment in July 2024 for further Chennai center expansions.
ALSO READ
-
Japanese Lawmakers Visit India to See Worker Protection and Skills Projects in Action
-
Indian Unions Push for Fair Recruitment and Rights for Care Workers in Germany
-
African Venture Capital Gets a Boost as Oxford Programme Builds Investor Connections
-
Cleaner Kitchens, Polluted Skies: Hidden Health Cost of India’s Electricity Boom
-
Japan-Backed ILO Projects Help 23,000 Workers Gain Rights and Fight Child Labour
Google News